-transparent.png){kind=logo}
Sertraline, a new selective 5-HT uptake inhibitor showed a mixed pattern of inhibition of human platelet 5-HT uptake with a Ki value of 2.5 nM and K'i value of 25 nM. Imipramine and alaproclate were found to be fully competitive inhibitors of 5-HT uptake with Ki values of 8 and 130 nM respectively. Sertraline was a fully competitive inhibitor of high-affinity [3H]imipramine binding to platelet membranes with a Ki value of 1.3 nM, as was alaproclate and 5-HT with Ki values of 170 and 800 nM respectively. Both sertraline and imipramine, at a concentration of 10 microM caused a fast monophasic dissociation of [3H]imipramine from platelet membranes in contrast to serotonin which caused a slow monophasic dissociation.
O M Phillips, and
K M Wood, and
D C Williams
February 1991,
Biochemical Society transactions,
O M Phillips, and
K M Wood, and
D C Williams
April 1990,
Journal of neurochemistry,
O M Phillips, and
K M Wood, and
D C Williams
January 1982,
General pharmacology,
O M Phillips, and
K M Wood, and
D C Williams
November 1978,
Biochemistry,
O M Phillips, and
K M Wood, and
D C Williams
July 1991,
Cephalalgia : an international journal of headache,
O M Phillips, and
K M Wood, and
D C Williams
July 1978,
Neuroscience letters,
O M Phillips, and
K M Wood, and
D C Williams
November 1956,
Experientia,
O M Phillips, and
K M Wood, and
D C Williams
November 1973,
American journal of clinical pathology,
O M Phillips, and
K M Wood, and
D C Williams
December 2001,
Experimental & molecular medicine,
O M Phillips, and
K M Wood, and
D C Williams
January 1975,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
